Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Canadian Patent Grant Strengthens Small Pharma’s International Position
Thursday, August 04, 2022Small Pharma Inc a biotechnology company focused on shortacting psychedelicassisted therapies for mental health conditions today announces that as of July it has been granted patent no by the Canadian Intellectual Property Office This Canadian pat...
MediWound Announces U.S. FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns
Wednesday, August 03, 2022MediWound Ltd a fullyintegrated biopharmaceutical company focused on nextgeneration biotherapeutic solutions for tissue repair and regeneration today announced that the US Food and Drug Administration FDA has accepted for review its recently resubmit...
Calidi Biotherapeutics Announces FDA Authorization of IND for a Phase 1 Clinical Trial of NeuroNova in Patients with Recurrent High-Grade Glioma
Tuesday, August 02, 2022Calidi Biotherapeutics Inc Calidi a clinicalstage biotechnology company that is pioneering allogeneic cellbased platforms to revolutionize oncolytic virus therapies is pleased to announce that City of Hope has received US Food and Drug Administration...
Innate Pharma Provides Update on AstraZeneca-Sponsored INTERLINK-1 Phase 3 Study
Monday, August 01, 2022Innate Pharma SA today announced that a planned futility interim analysis of the INTERLINK Phase study sponsored by AstraZeneca did not meet a predefined threshold for efficacy Based on this result and the recommendation of an Independent Data Monit...
Ipsen and Marengo Therapeutics Announce Strategic Partnership to Advance Two Precision Immuno-Oncology Candidates From Marengo’s STAR Platform Into the Clinic
Monday, August 01, 2022Ipsen and Marengo Therapeutics Inc today announced a strategic partnership to advance two of Marengos preclinical STAR platformgenerated candidates into the clinic The collaboration will leverage Marengos proprietary RD expertise of a novel mechanism...
Propanc Biopharma’s CSO Reflects on Unique Anti-Cancer Effects of PRP Discovered Over Past Decade
Thursday, July 28, 2022Propanc Biopharma Inc a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer today announced that Chief Scientific Officer and CoFounder Dr Julian Kenyon MD MB ChB reflects on the un...
Brii Biosciences Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination
Tuesday, July 26, 2022Brii Biosciences Limited a multinational company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens today announced new live virus data confirming that the amubarvimabromlusevimab combina...
GemPharmatech and Charles River Laboratories Sign Exclusive Agreement to Distribute Next Generation NCG Portfolio
Tuesday, July 26, 2022In order to bring new cuttingedge research models to the market to accelerate the development of novel therapeutics for a host of unmet medical needs particularly in immunooncology GemPharmatech GemPharmatech Co Ltd announced that it has entered into...
Beckman Coulter and Scopio Labs Partner to Accelerate Adoption of Hematology Digital Cell Morphology Platform
Wednesday, July 20, 2022Beckman Coulter a global leader in clinical diagnostics and Scopio Labs a medtech company that develops AIpowered workflow solutions announced today a worldwide partnership to accelerate adoption of Scopios next generation peripheral blood smear plat...
APONTIS PHARMA and Midas Pharma agree on further development partnership for the market launch of a single pill with pan-European intellectual property rights
Tuesday, July 19, 2022APONTIS PHARMA AG the leading pharmaceutical company for Single Pills in Germany has concluded a further development partnership with Midas Pharma as part of its growth strategy The objective is the contract development of a Single Pill with a combin...
